Literature DB >> 17364558

Hepatitis B virus and intrahepatic cholangiocarcinoma.

Nikolaos K Gatselis1, Konstantinos Tepetes, Argirios Loukopoulos, Katerina Vasiou, Athanasios Zafiriou, Chrisoula Gioti, Georgios N Dalekos.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer that arises from intrahepatic bile ducts. Its etiopathogenesis has been considered to be independent of the presence of chronic viral hepatitis infections or cirrhosis. These factors, particularly the hepatitis C virus, have been reported to play a role in the development of cholangiocarcinoma in a few studies, with inconclusive results. We report 2 cases of ICC that presented with a background of hepatitis B virus (HBV) infection and discuss the possible pathophysiological relationships between ICC and HBV infection, with an emphasis on the x gene of HBV.

Entities:  

Mesh:

Year:  2007        PMID: 17364558     DOI: 10.1080/07357900601130722

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Authors:  Ban Seok Lee; Eun-Cheol Park; Seung Woo Park; Chung Mo Nam; Jaehoon Roh
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

2.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

3.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

4.  Combined hepatocellular cholangiocarcinomas; analysis of a large database.

Authors:  Mitchell S Wachtel; Yan Zhang; Tom Xu; Maurizio Chiriva-Internati; Eldo E Frezza
Journal:  Clin Med Pathol       Date:  2008-03-19

5.  Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES).

Authors:  Hui Wang; Xin-Zu Chen; Xiao-Long Chen; Wei-Han Zhang; Kai Liu; You-Juan Wang; Huai-Rong Tang; Jian-Kun Hu
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.